Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![jfais20 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::2786447854.png) Jonathan Faison [@jfais20](/creator/twitter/jfais20) on x 10.1K followers
Created: 2025-07-16 20:23:23 UTC

$SRPT (NP)

+40% AH to $XX on label update for Elevidys & restructuring

Pivoting away from gene therapy to $ARWR siRNA for future growth


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945580040759960020/c:line.svg)

**Related Topics**
[1b](/topic/1b)
[$1b](/topic/$1b)
[$2b](/topic/$2b)
[chapter 11](/topic/chapter-11)
[$srpt](/topic/$srpt)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)
[$arwr](/topic/$arwr)

[Post Link](https://x.com/jfais20/status/1945580040759960020)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

jfais20 Avatar Jonathan Faison @jfais20 on x 10.1K followers Created: 2025-07-16 20:23:23 UTC

$SRPT (NP)

+40% AH to $XX on label update for Elevidys & restructuring

Pivoting away from gene therapy to $ARWR siRNA for future growth

XXXXX engagements

Engagements Line Chart

Related Topics 1b $1b $2b chapter 11 $srpt sarepta therapeutics inc stocks healthcare $arwr

Post Link

post/tweet::1945580040759960020
/post/tweet::1945580040759960020